| Literature DB >> 33967946 |
Ruijie Wang1, Daogong Zhang1, Jianfen Luo1, Xiuhua Chao1, Jiliang Xu1, Xianfeng Liu1, Zhaomin Fan1, Haibo Wang1, Lei Xu1.
Abstract
Background: Cochlear implantation (CI) is becoming increasingly used in the rehabilitation of hearing-impaired patients. Children with an enlarged vestibular aqueduct (EVA) need CI for severe or profound hearing loss, with excellent outcomes in hearing rehabilitation. However, vestibular function influenced by CI in children with EVA has not been clarified. We compared the characteristics of vestibular function in implanted children with EVA and those with a normal cochlea.Entities:
Keywords: EVA; child; cochlear implant; vestibular function; vestibular-evoked myogenic potential
Year: 2021 PMID: 33967946 PMCID: PMC8099028 DOI: 10.3389/fneur.2021.663123
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Demographic characteristics of the 32 patients in this study.
| Study | S1 | M | L | Congenital | 6 | EVA | CI422 | RW |
| S2 | M | R | Congenital | 7 | EVA | CI422 | RW | |
| S3 | M | L | Congenital | 5 | MD, EVA | CI422 | RW | |
| S4 | M | L | Congenital | 8 | EVA | CI24RECA | Extended | |
| S5 | M | R | Congenital | 5 | EVA | CI422 | RW | |
| S6 | M | L | Congenital | 11 | MD, EVA | CS-10A | RW | |
| S7 | F | R | Congenital | 5 | MD, EVA | CI422 | RW | |
| S8 | M | R | Congenital | 6 | EVA | CI24RECA | Extended | |
| S9 | M | R | Progressive | 15 | MD, EVA | CI24RECA | Extended | |
| S10 | F | R | Congenital | 13 | MD, EVA | CI422 | RW | |
| S11 | F | R | Progressive | 17 | MD, EVA | CI422 | RW | |
| S12 | F | R | Congenital | 6 | MD, EVA | FLEX F28 | Extended | |
| S13 | M | R | Congenital | 7 | MD, EVA | CI422 | RW | |
| S14 | M | R | Congenital | 14 | MD, EVA | CI422 | RW | |
| S15 | M | R | Progressive | 16 | EVA | CI422 | RW | |
| S16 | F | R | Congenital | 6 | MD, EVA | CI422 | RW | |
| Control | C1 | F | R | Progressive | 18 | Normal | CI24RECA | Extended |
| C2 | M | L | Progressive | 12 | Normal | CS-10A | RW | |
| C3 | M | R | Progressive | 16 | Normal | CS-10A | RW | |
| C4 | F | R | Progressive | 12 | Normal | CI24RECA | Extended | |
| C5 | M | R | Congenital | 5 | Normal | CI24RECA | Extended | |
| C6 | M | L | Progressive | 18 | Normal | CI422 | RW | |
| C7 | M | R | Progressive | 17 | Normal | CI422 | RW | |
| C8 | M | R | Congenital | 7 | Normal | CI422 | RW | |
| C9 | F | R | Congenital | 6 | Normal | CI24RECA | Extended | |
| C10 | M | R | Progressive | 13 | Normal | CI422 | RW | |
| C11 | M | R | Progressive | 12 | Normal | CI422 | RW | |
| C12 | M | L | Progressive | 13 | Normal | CI422 | RW | |
| C13 | F | R | Congenital | 11 | Normal | CI24RECA | Extended | |
| C14 | M | L | Congenital | 10 | Normal | CI24RECA | Extended | |
| C15 | M | R | Congenital | 7 | Normal | FLEX F28 | RW | |
| C16 | F | L | Congenital | 6 | Normal | CI422 | RW |
RW, round window; Extended, extended RW; EVA, enlarged vestibular aqueduct; MD, Mondini; M, male; F, female; L, left; R, right.
Specific parameters of VEMPs in the Study Group and the Control Group before and after implantation.
| cVEMP | Study | 14 | 15.38 ± 2.82 | 23.55 ± 4.48 | 94.04 ± 51.27 | 13.66 ± 0.71 | 25.77 ± 16.54 | 110.96 ± 60.94 |
| Control | 5 | 13.85 ± 2.58 | 21.55 ± 2.59 | 162.19 ± 122.92 | 15.38 ± 2.82 | 21.76 ± 1.59 | 89.90 ± 43.11 | |
| oVEMP | Study | 14 | 14.28 ± 0.96 | 9.86 ± 0.51 | 15.18 ± 8.51 | 14.79 ± 1.33 | 10.39 ± 1.25 | 8.16 ± 5.49 |
| Control | 5 | 15.87 ± 1.42 | 11.80 ± 2.26 | 9.04 ± 10.73 | 15.03 ± 1.48 | 11.48 ± 1.61 | 10.50 ± 13.03 |
The first positive wave in the cVEMP waveform is P1, and the first negative wave is N1. The first negative wave in the oVEMP waveform is N1, and the first positive wave is P1. P1, ms; N1, ms; Amplitude, μV. T▾, tested ears of patients with both pre-operative and post-operative present VEMPs; patients with present VEMPs preoperatively and absent VEMPs postoperatively were not included. cVEMP, cervical vestibular-evoked myogenic potential; oVEMP, ocular vestibular-evoked myogenic potential; pre, pre-operation; post, post-operation;
p < 0.05.
The VOR gains in the vHIT in the Study Group and the Control Group before and after implantation.
| Study | 16 | 1.03 ± 0.08 | 1.02 ± 0.06 | 0.98 ± 0.09 | 0.98 ± 0.18 | 0.90 ± 0.28 | 0.94 ± 0.13 | |
| Control | 16 | 1.01 ± 0.07 | 0.98 ± 0.08 | 0.99 ± 0.10 | 1.05 ± 0.07 | 1.01 ± 0.08 | 1.00 ± 0.09 |
Pre, pre-operation; post, post-operation; T, test ears; vHIT, video head impulse test; HSC, horizontal semicircular canal; SSC, superior semicircular canal; PSC, posterior semicircular canal.
The VEMP response in 32 implanted children and correlation to electrode and surgical approach after CI.
| CI422 | 12 | 6 | 11 | 7 |
| CI24RECA | 4 | 5 | 4 | 5 |
| FLEX 28 | 1 | 1 | 1 | 1 |
| CS-10A | 3 | 0 | 2 | 1 |
| RW | 15 | 7 | 13 | 9 |
| Extended RW | 5 | 5 | 5 | 5 |
Chi-square test. cVEMP, cervical vestibular-evoked myogenic potential; oVEMP, ocular vestibular-evoked myogenic potential; RW, round window; Extended, extended RW; n, number of patient.
Figure 1The response rates of cVEMP and oVEMP at postoperative month 12 (%). Chi-square test, the response rate of cVEMP (Study Group vs. Control Group, p = 0.028), the response rate of oVEMP (Study Group vs. Control Group, p = 0.033), *p < 0.05. cVEMP, cervical vestibular-evoked myogenic potential; oVEMP, ocular vestibular-evoked myogenic potential; Study, Study Group; Control, Control Group.